Ardelyx (ARDX) Amortization - Intangibles (2022 - 2023)
Ardelyx (ARDX) reported Amortization - Intangibles of $1.0 million for Q4 2023, up 21.19% on a YoY basis from $859000.0 in Q4 2022, and up 15.67% quarter-over-quarter from $900000.0 in Q3 2023.
Ardelyx (ARDX) Amortization - Intangibles (2022 - 2023) Analysis & Trends
Ardelyx has reported Amortization - Intangibles for 2 years, with the latest figure at $1.0 million in Q4 2023.
- For the quarter ending Q4 2023, Amortization - Intangibles rose 21.19% year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2023 stood at $3.9 million (up 135.68% YoY), and the FY2023 full-year result was $3.9 million, up 129.41% from the prior year.
- Amortization - Intangibles for Q4 2023 stood at $1.0 million, up from $900000.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $1.0 million in Q4 2023, with the low at $800000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 969,000.00 |
| Dec 31, 2022 | 859,000.00 |
| Sep 30, 2022 | 800,000.00 |